Advertisement

Topics

Shire mulls over separation of neuroscience unit

04:10 EDT 4 Aug 2017 | PharmaTimes

Shire is considering cleaving its neuroscience division into a separate, publicly-listed entity in a move that would afford the firm a sharper focus on rare disease diseases.

Original Article: Shire mulls over separation of neuroscience unit

NEXT ARTICLE

More From BioPortfolio on "Shire mulls over separation of neuroscience unit"

Quick Search
Advertisement